Cholinesterase inhibitors: Drugs looking for a disease?
2006

Cholinesterase Inhibitors: Drugs Looking for a Disease?

Sample size: 5462 publication Evidence: low

Author Information

Author(s): Marina Maggini, Nicola Vanacore, Roberto Raschetti

Primary Institution: National Center for Epidemiology, National Institute of Health, Rome, Italy

Hypothesis

What is the evidence for the effectiveness of cholinesterase inhibitors in treating dementia?

Conclusion

Cholinesterase inhibitors have not led to proven improvements in patients' well-being despite their use in treating dementia.

Supporting Evidence

  • Cholinesterase inhibitors have been shown to have modest effects in clinical trials.
  • The efficacy of these drugs is often presented in a way that may create a false perception of their effectiveness.
  • Many trials used unvalidated scales for measuring outcomes, which undermines their clinical relevance.
  • The NICE committee concluded that the evidence for the effectiveness of cholinesterase inhibitors is limited and inconclusive.

Takeaway

Doctors are using certain drugs to help people with dementia, but they don't really work as well as we hoped.

Methodology

The article reviews randomized controlled trials and systematic reviews of cholinesterase inhibitors for dementia.

Potential Biases

There are concerns about selection bias, measurement bias, and attrition bias in the reviewed trials.

Limitations

Many trials had restrictive inclusion criteria and did not represent the general patient population.

Participant Demographics

The studies included patients with various types of dementia, including Alzheimer's disease and vascular dementia.

Statistical Information

Confidence Interval

95% confidence interval, 4%–17%

Digital Object Identifier (DOI)

10.1371/journal.pmed.0030140

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication